News
2d
Stocktwits on MSNCMS’s Initial Proposal To Cover Renal Denervation A Win For Medtronic, Says AnalystsAnalysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...
On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ...
CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...
3h
Zacks Investment Research on MSNHospital Capex Headwind: Temporary Setback or Lasting Risk for ISRG?Intuitive Surgical ISRG entered 2025 with strong momentum — da Vinci system placements grew 17% year over year and procedures ...
3d
GlobalData on MSNGeneticure’s test obtains US patent to predict renal denervation responseThe patented method uses genetic markers and a weighted algorithm to assess the responsiveness to renal denervation.
About the Paradise Ultrasound Renal Denervation System The Paradise uRDN system is a first-of-its-kind ultrasound-based RDN ...
Medtronic and Recor Medical stand to benefit from national Medicare coverage for their new device-based treatments for patients with uncontrolled high blood pressure.
Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation ...
The Centers for Medicare & Medicaid Services (CMS) issued a proposed decision memo for its National Coverage Analysis (NCA) ...
Medtronic is studying the use of its nitinol-enabled Symplicity Spyral renal denervation (RDN) catheter combined with hepatic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results